Case Report: Pulmonary Alveolar Calcification as a Result of Severe Hypercalcemia due to Acute Lymphoblatic Leukemia

Jose Colleti Junior1, Eliana Carla Armelin Benites2, Gustavo Spadaccia Dos Santos Fernandes3

  • 1Pediatric Intensive Care Unit, Santa Catarina Hospital , São Paulo, 01310 000, Brazil.

F1000Research
|July 28, 2015
PubMed

Insights

Severe hypercalcemia in a toddler, a rare metabolic disorder, was successfully treated with pamidronate. This case highlights hypercalcemia as a potential early sign of acute lymphoblastic leukemia (ALL).

Area of Science:

  • Pediatric Endocrinology
  • Pediatric Oncology
  • Metabolic Disorders

Background:

  • Severe hypercalcemia is an uncommon metabolic disorder in children.
  • It can present with significant clinical manifestations and radiological findings, including osteolytic lesions and pulmonary calcification.
  • Hypercalcemia as an initial presentation of acute lymphoblastic leukemia (ALL) is rare.

Purpose of the Study:

  • To report a rare case of severe hypercalcemia in a pediatric patient.
  • To describe the clinical and radiological features associated with severe hypercalcemia.
  • To emphasize the importance of considering ALL in cases of unexplained severe hypercalcemia.

Main Methods:

  • Case report of a 2-year-old toddler with severe hypercalcemia.
  • Clinical evaluation, radiological imaging (osteolytic lesions, pulmonary alveolar calcification).
  • Treatment with pamidronate (a bisphosphonate) and subsequent diagnostic workup for underlying causes.

Main Results:

  • The patient presented with severe hypercalcemia, osteolytic lesions, and massive pulmonary alveolar calcification.
  • Pamidronate effectively managed the hypercalcemia.
  • Further investigations revealed a diagnosis of acute lymphoblastic leukemia (ALL).

Conclusions:

  • Severe hypercalcemia can be a presenting sign of acute lymphoblastic leukemia (ALL) in pediatric patients.
  • Radiological findings can be indicative of hypercalcemia-induced complications.
  • Prompt diagnosis and treatment, including bisphosphonates for hypercalcemia and chemotherapy for ALL, are crucial for favorable outcomes.

Related Concept Videos

Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.2K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.2K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.1K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.4K
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
1.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.1K